Laurel A. Omert
Keine laufenden Positionen mehr
Karriereverlauf von Laurel A. Omert
Ehemalige bekannte Positionen von Laurel A. Omert
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Northfield Laboratories, Inc.
Northfield Laboratories, Inc. BiotechnologyHealth Technology The Company's principal activity is to develop, manufacture, market and distribute a hemoglobin-based blood substitute product. The Company's product, PolyHeme(R) blood substitute, provides an alternative to transfused blood for use in the treatment of acute blood loss. The company uses a proprietary process of separation, filtration, chemical modification purification and formulation to produce PolyHeme. PolyHeme is designed to avoid potential undesirable effects such as vasoconstriction, kidney dysfunction, liver dysfunction and gastrointestinal distress. Clinical trials of PolyHeme have been conducted at multiple locations in the United States. The company has entered into license agreements with Pfizer Inc and Hemocare Ltd an Israeli corporation to develop manufacture and distribute PolyHeme in certain European, Middle Eastern and African countries. The Company is in development stage. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2005 | 08.05.2009 |
Drexel University | Corporate Officer/Principal | 01.01.1997 | 10.01.2005 |
Allegheny General Hospital, Inc.
Allegheny General Hospital, Inc. Hospital/Nursing ManagementHealth Services Allegheny General Hospital, Inc. provides healthcare services. The firm offers traditional, medical, and surgical services as well as cardiology care and organ transplants. It also engages in research areas such as neuroscience, oncology, genetics, and trauma. The company was founded in 1885 and is headquartered in Pittsburgh, PA. | Corporate Officer/Principal | 01.01.1997 | 01.01.2005 |
West Virginia University | Corporate Officer/Principal | - | - |
Ausbildung von Laurel A. Omert
Yale University | Undergraduate Degree |
Loyola University New Orleans | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Operativ
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 1 |
Undergraduate Degree | 1 |
Sektoral
Consumer Services | 5 |
Health Technology | 2 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Northfield Laboratories, Inc.
Northfield Laboratories, Inc. BiotechnologyHealth Technology The Company's principal activity is to develop, manufacture, market and distribute a hemoglobin-based blood substitute product. The Company's product, PolyHeme(R) blood substitute, provides an alternative to transfused blood for use in the treatment of acute blood loss. The company uses a proprietary process of separation, filtration, chemical modification purification and formulation to produce PolyHeme. PolyHeme is designed to avoid potential undesirable effects such as vasoconstriction, kidney dysfunction, liver dysfunction and gastrointestinal distress. Clinical trials of PolyHeme have been conducted at multiple locations in the United States. The company has entered into license agreements with Pfizer Inc and Hemocare Ltd an Israeli corporation to develop manufacture and distribute PolyHeme in certain European, Middle Eastern and African countries. The Company is in development stage. | Health Technology |
Allegheny General Hospital, Inc.
Allegheny General Hospital, Inc. Hospital/Nursing ManagementHealth Services Allegheny General Hospital, Inc. provides healthcare services. The firm offers traditional, medical, and surgical services as well as cardiology care and organ transplants. It also engages in research areas such as neuroscience, oncology, genetics, and trauma. The company was founded in 1885 and is headquartered in Pittsburgh, PA. | Health Services |
- Börse
- Insiders
- Laurel A. Omert
- Erfahrung